OSBPL1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.125800E-01
Normal-vs-Stage2
7.339200E-01
Normal-vs-Stage3
8.608000E-01
Normal-vs-Stage4
3.746400E-01
Stage1-vs-Stage2
1.586790E-01
Stage1-vs-Stage3
8.605200E-01
Stage1-vs-Stage4
6.364200E-02
Stage2-vs-Stage3
5.859200E-01
Stage2-vs-Stage4
6.678400E-01
Stage3-vs-Stage4
6.874000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.119400E-01
Normal-vs-AfricanAmerican
4.790000E-01
Normal-vs-Asian
8.113800E-01
Caucasian-vs-AfricanAmerican
6.685600E-01
Caucasian-vs-Asian
9.851600E-01
AfricanAmerican-vs-Asian
6.830200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.936800E-01
Normal-vs-Female
7.176400E-01
Male-vs-Female
8.736200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.048800E-01
Normal-vs-Age(41-60Yrs)
5.707000E-01
Normal-vs-Age(61-80Yrs)
9.171000E-01
Normal-vs-Age(81-100Yrs)
8.246400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.221200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.198000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.877600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.237900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.108300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.572200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.203400E-01
Normal-vs-Daily Drinker
6.544400E-01
Normal-vs-Weekly Drinker
8.293600E-01
Normal-vs-Occasional Drinker
9.997200E-01
Normal-vs-Social Drinker
9.494600E-01
Non Drinker-vs-Daily Drinker
2.050200E-01
Non Drinker-vs-Weekly Drinker
5.850400E-01
Non Drinker-vs-Occasional Drinker
8.332800E-01
Non Drinker-vs-Social Drinker
7.487400E-01
Daily Drinker-vs-Weekly Drinker
3.047000E-01
Daily Drinker-vs-Occasional Drinker
2.474800E-01
Daily Drinker-vs-Social Drinker
3.041000E-01
Weekly Drinker-vs-Occasional Drinker
7.327400E-01
Weekly Drinker-vs-Social Drinker
8.851800E-01
Occasional Drinker-vs-Social Drinker
8.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.812200E-01
Normal-vs-Grade 2
3.572600E-01
Normal-vs-Grade 3
3.484000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.882900E-03
Grade 1-vs-Grade 3
2.023800E-01
Grade 1-vs-Grade 4
4.812200E-01
Grade 2-vs-Grade 3
1.565590E-01
Grade 2-vs-Grade 4
3.572600E-01
Grade 3-vs-Grade 4
3.484000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.194800E-01
Normal-vs-NonDiabetic
7.291200E-01
Diabetic-vs-NonDiabetic
8.664300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.550600E-01
Normal-vs-NoPancreatitis
7.744800E-01
Pancreatitis-vs-NoPancreatitis
6.561000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.594800E-01
Normal-vs-N1
6.826200E-01
N0-vs-N1
1.354210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.090800E-01
Normal-vs-TP53-NonMutant
9.675600E-01
TP53-Mutant-vs-TP53-NonMutant
1.064380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
